Mechanisms of activation and repression by the alternative splicing factors RBFOX1/2

  1. Adrian R. Krainer1,6
  1. 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
  2. 2Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
    • 3 Present address: Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA 92093, USA.

    • 4 Present address: Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ 07065, USA.

    • 5 Present address: Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

    Abstract

    RBFOX1 and RBFOX2 are alternative splicing factors that are predominantly expressed in the brain and skeletal muscle. They specifically bind the RNA element UGCAUG, and regulate alternative splicing positively or negatively in a position-dependent manner. The molecular basis for the position dependence of these and other splicing factors on alternative splicing of their targets is not known. We explored the mechanisms of RBFOX splicing activation and repression using an MS2-tethering assay. We found that the Ala/Tyr/Gly-rich C-terminal domain is sufficient for exon activation when tethered to the downstream intron, whereas both the C-terminal domain and the central RRM are required for exon repression when tethered to the upstream intron. Using immunoprecipitation and mass spectrometry, we identified hnRNP H1, RALY, and TFG as proteins that specifically interact with the C-terminal domain of RBFOX1 and RBFOX2. RNA interference experiments showed that hnRNP H1 and TFG modulate the splicing activity of RBFOX1/2, whereas RALY had no effect. However, TFG is localized in the cytoplasm, and likely modulates alternative splicing indirectly.

    Keywords

    Footnotes

    • Received September 21, 2011.
    • Accepted November 9, 2011.
    | Table of Contents